VCYT logo

Veracyte, Inc. (VCYT) EBITDA

annual EBITDA:

$42.97M+$92.38M(+186.97%)
December 31, 2024

Summary

  • As of today (September 12, 2025), VCYT annual EBITDA is $42.97 million, with the most recent change of +$92.38 million (+186.97%) on December 31, 2024.
  • During the last 3 years, VCYT annual EBITDA has risen by +$104.78 million (+169.51%).
  • VCYT annual EBITDA is now at all-time high.

Performance

VCYT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVCYTincome statement metrics

quarterly EBITDA:

$19.80M+$13.49M(+213.70%)
June 30, 2025

Summary

  • As of today (September 12, 2025), VCYT quarterly EBITDA is $19.80 million, with the most recent change of +$13.49 million (+213.70%) on June 30, 2025.
  • Over the past year, VCYT quarterly EBITDA has increased by +$9.36 million (+89.59%).
  • VCYT quarterly EBITDA is now at all-time high.

Performance

VCYT quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVCYTincome statement metrics

TTM EBITDA:

$61.50M+$9.36M(+17.95%)
June 30, 2025

Summary

  • As of today (September 12, 2025), VCYT TTM EBITDA is $61.50 million, with the most recent change of +$9.36 million (+17.95%) on June 30, 2025.
  • Over the past year, VCYT TTM EBITDA has increased by +$29.10 million (+89.80%).
  • VCYT TTM EBITDA is now at all-time high.

Performance

VCYT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVCYTincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

VCYT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+187.0%+89.6%+89.8%
3 y3 years+169.5%+720.1%+513.7%
5 y5 years+650.5%+323.6%+331.5%

VCYT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+169.5%at high+720.1%at high+502.8%
5 y5-yearat high+169.5%at high+323.6%at high+326.7%
alltimeall timeat high+169.5%at high+298.1%at high+280.2%

VCYT EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$19.80M(+213.7%)
$61.50M(+17.9%)
Mar 2025
-
$6.31M(-63.5%)
$52.14M(+10.5%)
Dec 2024
$42.97M(-187.0%)
$17.31M(-4.3%)
$47.19M(+35.6%)
Sep 2024
-
$18.08M(+73.1%)
$34.80M(+7.4%)
Jun 2024
-
$10.44M(+666.3%)
$32.40M(+48.4%)
Mar 2024
-
$1.36M(-72.3%)
$21.84M(+24.4%)
Dec 2023
-$49.41M(+379.7%)
$4.91M(-68.7%)
$17.55M(+1.8%)
Sep 2023
-
$15.68M(<-9900.0%)
$17.25M(-1925.0%)
Jun 2023
-
-$118.00K(-96.0%)
-$945.00K(-76.5%)
Mar 2023
-
-$2.92M(-163.5%)
-$4.02M(-56.3%)
Dec 2022
-$10.30M(-83.3%)
$4.61M(-283.7%)
-$9.20M(-39.7%)
Sep 2022
-
-$2.51M(-21.5%)
-$15.27M(+2.7%)
Jun 2022
-
-$3.19M(-60.6%)
-$14.87M(+6.0%)
Mar 2022
-
-$8.11M(+454.0%)
-$14.02M(+149.4%)
Dec 2021
-$61.81M(+131.2%)
-$1.46M(-30.5%)
-$5.62M(-27.8%)
Sep 2021
-
-$2.11M(-10.3%)
-$7.78M(+10.6%)
Jun 2021
-
-$2.35M(-901.0%)
-$7.04M(-48.1%)
Mar 2021
-
$293.00K(-108.1%)
-$13.55M(-43.2%)
Dec 2020
-$26.74M(+242.5%)
-$3.62M(+166.4%)
-$23.84M(-12.1%)
Sep 2020
-
-$1.36M(-84.6%)
-$27.13M(+2.1%)
Jun 2020
-
-$8.86M(-11.4%)
-$26.57M(+33.6%)
Mar 2020
-
-$10.00M(+44.5%)
-$19.89M(+80.6%)
Dec 2019
-$7.80M(-54.4%)
-$6.92M(+767.8%)
-$11.01M(+78.1%)
Sep 2019
-
-$797.00K(-63.4%)
-$6.18M(-29.0%)
Jun 2019
-
-$2.18M(+93.9%)
-$8.71M(-24.0%)
Mar 2019
-
-$1.12M(-46.2%)
-$11.46M(-37.4%)
Dec 2018
-$17.12M
-$2.09M(-37.2%)
-$18.31M(-13.9%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$3.32M(-32.6%)
-$21.27M(-8.8%)
Jun 2018
-
-$4.93M(-38.2%)
-$23.32M(-3.1%)
Mar 2018
-
-$7.97M(+58.2%)
-$24.06M(+6.0%)
Dec 2017
-$23.76M(-5.5%)
-$5.04M(-6.2%)
-$22.70M(+11.2%)
Sep 2017
-
-$5.38M(-5.1%)
-$20.42M(+7.3%)
Jun 2017
-
-$5.67M(-14.4%)
-$19.03M(-17.0%)
Mar 2017
-
-$6.62M(+139.4%)
-$22.92M(-9.4%)
Dec 2016
-$25.14M(-19.1%)
-$2.76M(-30.7%)
-$25.29M(-15.3%)
Sep 2016
-
-$3.99M(-58.3%)
-$29.87M(-12.5%)
Jun 2016
-
-$9.55M(+6.3%)
-$34.12M(+3.4%)
Mar 2016
-
-$8.99M(+22.5%)
-$33.00M(+5.7%)
Dec 2015
-$31.07M(+11.9%)
-$7.34M(-11.0%)
-$31.21M(-1.2%)
Sep 2015
-
-$8.24M(-2.2%)
-$31.59M(+8.7%)
Jun 2015
-
-$8.43M(+17.1%)
-$29.06M(+8.0%)
Mar 2015
-
-$7.20M(-6.7%)
-$26.92M(+3.4%)
Dec 2014
-$27.76M(+14.0%)
-$7.72M(+35.0%)
-$26.03M(+9.4%)
Sep 2014
-
-$5.72M(-9.0%)
-$23.79M(-0.4%)
Jun 2014
-
-$6.28M(-0.4%)
-$23.89M(+4.8%)
Mar 2014
-
-$6.31M(+15.2%)
-$22.79M(+2.8%)
Dec 2013
-$24.35M(+35.7%)
-$5.48M(-5.7%)
-$22.17M(+2.5%)
Sep 2013
-
-$5.81M(+12.1%)
-$21.63M(+5.1%)
Jun 2013
-
-$5.19M(-9.0%)
-$20.58M(+3.7%)
Mar 2013
-
-$5.70M(+15.4%)
-$19.84M(+8.9%)
Dec 2012
-$17.94M(+29.7%)
-$4.94M(+3.7%)
-$18.22M(+37.1%)
Sep 2012
-
-$4.76M(+7.0%)
-$13.29M(+55.9%)
Jun 2012
-
-$4.45M(+9.2%)
-$8.53M(+109.2%)
Mar 2012
-
-$4.08M
-$4.08M
Dec 2011
-$13.83M
-
-

FAQ

  • What is Veracyte, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Veracyte, Inc.?
  • What is Veracyte, Inc. annual EBITDA year-on-year change?
  • What is Veracyte, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Veracyte, Inc.?
  • What is Veracyte, Inc. quarterly EBITDA year-on-year change?
  • What is Veracyte, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Veracyte, Inc.?
  • What is Veracyte, Inc. TTM EBITDA year-on-year change?

What is Veracyte, Inc. annual EBITDA?

The current annual EBITDA of VCYT is $42.97M

What is the all time high annual EBITDA for Veracyte, Inc.?

Veracyte, Inc. all-time high annual EBITDA is $42.97M

What is Veracyte, Inc. annual EBITDA year-on-year change?

Over the past year, VCYT annual EBITDA has changed by +$92.38M (+186.97%)

What is Veracyte, Inc. quarterly EBITDA?

The current quarterly EBITDA of VCYT is $19.80M

What is the all time high quarterly EBITDA for Veracyte, Inc.?

Veracyte, Inc. all-time high quarterly EBITDA is $19.80M

What is Veracyte, Inc. quarterly EBITDA year-on-year change?

Over the past year, VCYT quarterly EBITDA has changed by +$9.36M (+89.59%)

What is Veracyte, Inc. TTM EBITDA?

The current TTM EBITDA of VCYT is $61.50M

What is the all time high TTM EBITDA for Veracyte, Inc.?

Veracyte, Inc. all-time high TTM EBITDA is $61.50M

What is Veracyte, Inc. TTM EBITDA year-on-year change?

Over the past year, VCYT TTM EBITDA has changed by +$29.10M (+89.80%)
On this page